{"id":957516,"date":"2026-05-04T08:10:23","date_gmt":"2026-05-04T12:10:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/"},"modified":"2026-05-04T08:10:23","modified_gmt":"2026-05-04T12:10:23","slug":"4dmt-to-participate-in-upcoming-investor-conferences-7","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/","title":{"rendered":"4DMT to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">EMERYVILLE, Calif., May  04, 2026  (GLOBE NEWSWIRE) &#8212; 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in May.<\/p>\n<p>\n        <strong>BofA Securities 2026 Healthcare Conference<\/strong><br \/>\n        \n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%;vertical-align: top\">Presentation Date:<\/td>\n<td style=\"max-width:80%;width:80%;min-width:80%;vertical-align: top\">Wednesday, May 13, 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Presentation Time:<\/td>\n<td style=\"vertical-align: top\">1:40 p.m. PT<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>RBC 2026 Global Healthcare Conference<\/strong><br \/>\n        \n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%;vertical-align: top\">Presentation Date:<\/td>\n<td style=\"max-width:80%;width:80%;min-width:80%;vertical-align: top\">Tuesday, May 19, 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Presentation Time:<\/td>\n<td style=\"vertical-align: top\">2:35 p.m. ET<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>Archived copies of the webcasts will be available for up to one year on the \u201cInvestors\u201d section of the 4DMT website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HcRuQ9kIbqsi5LlrmlNGEdSZDDSZM08F67o200xRvktgk2EiBQob1KpYGR9AG0lc1IQCcRLZjYIrTZt9WvWPMvCm-bVVfXlXfTI4H_oWKRB2QbW6NwCqEU3hgFdUIAHRVHm2u_-eUrw1Q0K8NiVD5AnUcI7HMGb49ngamXJvFEA=\" rel=\"nofollow\" target=\"_blank\"><u>https:\/\/ir.4dmoleculartherapeutics.com\/events<\/u><\/a>.<\/p>\n<p>\n        <strong>About 4DMT<\/strong> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p>4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company\u2019s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF biologics (aflibercept and anti-VEGF-C) with a single, safe, intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. The Company\u2019s lead indication for 4D-150 is wet age-related macular degeneration, which is currently in Phase 3 development, and second indication is diabetic macular edema. The Company\u2019s second product candidate is 4D-710, which is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery. 4D Molecular Therapeutics\u2122, 4DMT\u2122, Therapeutic Vector Evolution\u2122, and the 4DMT logo are trademarks of 4DMT.<\/p>\n<p>All of the Company\u2019s product candidates are in clinical or preclinical development and have not yet been approved for marketing by the U.S. Food and Drug Administration or any other regulatory authority. No representation is made as to the safety or effectiveness of the Company\u2019s product candidates for the therapeutic uses for which they are being studied.<\/p>\n<p>Learn more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=atLZcToteouCWSOWA5wgqgs6DIWK95xcRWLYowoDXZxN_GcNc7zYSdwwTRzdHrg4XCNThrePi17UCv89QzSZWCWe88CLbnj0OIgbrMx6LvU=\" rel=\"nofollow\" target=\"_blank\"><u>www.4DMT.com<\/u><\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QIjZ0-p50GhRcRGfOVD3Wiy3yvh3KbAP11EDcNxLLLtNqgMwbYrKyNaI_7Kt00QZ8C8fJZakkkC1axLCcpZMl6s5KG4CG2izsDf04paxcvtIgj-9RxozKrDyuCqRpy2RKuY7Hz8zXzh6w5Ayo1S1gQ==\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong>Media:<\/strong>\n      <\/p>\n<p>Jenn Gordon<br \/>dna Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=a32qJQ3dZgobUq7_ZgvX467QFgG9y4xmMDTi6BB1XVn56eh3xWgvstVDuNkNyTayHohE4AJz3dn8bDRBgZ2y7Q==\" rel=\"nofollow\" target=\"_blank\"><u>Media@4DMT.com<\/u><\/a><\/p>\n<p>\n        <strong>Investors:<\/strong>\n      <\/p>\n<p>Julian Pei<br \/>Head of Investor Relations and Strategic Finance<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=euz88_-l331HOMZl7IdCn14l6JmLfg-vUI-nfwa-PJlxG41Yt1-k7BKHUfhNTbZQFYYGy7zP_8ftztcxNVyS_blNLW8IkTqPrlbBHhskbfT8RxxMY6UhaPcxMTVn8KN2\" rel=\"nofollow\" target=\"_blank\"><u>Investor.Relations@4DMT.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU0NyM3NTc4Mzc3IzIxOTAxMTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzQ5YTgzY2UtZGQzOC00MjEzLWIwMmEtM2I3Njc4NTQ0NWUwLTEyMDE2NjktMjAyNi0wNS0wNC1lbg==\/tiny\/4D-Molecular-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>EMERYVILLE, Calif., May 04, 2026 (GLOBE NEWSWIRE) &#8212; 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in May. BofA Securities 2026 Healthcare Conference Presentation Date: Wednesday, May 13, 2026 Presentation Time: 1:40 p.m. PT \u00a0 \u00a0 RBC 2026 Global Healthcare Conference Presentation Date: Tuesday, May 19, 2026 Presentation Time: 2:35 p.m. ET \u00a0 \u00a0 Archived copies of the webcasts will be available for up to one year on the \u201cInvestors\u201d section of the 4DMT website at https:\/\/ir.4dmoleculartherapeutics.com\/events. About 4DMT \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 4DMT is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;4DMT to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-957516","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>4DMT to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"4DMT to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"EMERYVILLE, Calif., May 04, 2026 (GLOBE NEWSWIRE) &#8212; 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in May. BofA Securities 2026 Healthcare Conference Presentation Date: Wednesday, May 13, 2026 Presentation Time: 1:40 p.m. PT \u00a0 \u00a0 RBC 2026 Global Healthcare Conference Presentation Date: Tuesday, May 19, 2026 Presentation Time: 2:35 p.m. ET \u00a0 \u00a0 Archived copies of the webcasts will be available for up to one year on the \u201cInvestors\u201d section of the 4DMT website at https:\/\/ir.4dmoleculartherapeutics.com\/events. About 4DMT \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 4DMT is &hellip; Continue reading &quot;4DMT to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-04T12:10:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU0NyM3NTc4Mzc3IzIxOTAxMTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4dmt-to-participate-in-upcoming-investor-conferences-7\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4dmt-to-participate-in-upcoming-investor-conferences-7\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"4DMT to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-05-04T12:10:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4dmt-to-participate-in-upcoming-investor-conferences-7\\\/\"},\"wordCount\":360,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4dmt-to-participate-in-upcoming-investor-conferences-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMTU0NyM3NTc4Mzc3IzIxOTAxMTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4dmt-to-participate-in-upcoming-investor-conferences-7\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4dmt-to-participate-in-upcoming-investor-conferences-7\\\/\",\"name\":\"4DMT to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4dmt-to-participate-in-upcoming-investor-conferences-7\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4dmt-to-participate-in-upcoming-investor-conferences-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMTU0NyM3NTc4Mzc3IzIxOTAxMTY=\",\"datePublished\":\"2026-05-04T12:10:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4dmt-to-participate-in-upcoming-investor-conferences-7\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4dmt-to-participate-in-upcoming-investor-conferences-7\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4dmt-to-participate-in-upcoming-investor-conferences-7\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMTU0NyM3NTc4Mzc3IzIxOTAxMTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMTU0NyM3NTc4Mzc3IzIxOTAxMTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/4dmt-to-participate-in-upcoming-investor-conferences-7\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"4DMT to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"4DMT to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/","og_locale":"en_US","og_type":"article","og_title":"4DMT to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"EMERYVILLE, Calif., May 04, 2026 (GLOBE NEWSWIRE) &#8212; 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in May. BofA Securities 2026 Healthcare Conference Presentation Date: Wednesday, May 13, 2026 Presentation Time: 1:40 p.m. PT \u00a0 \u00a0 RBC 2026 Global Healthcare Conference Presentation Date: Tuesday, May 19, 2026 Presentation Time: 2:35 p.m. ET \u00a0 \u00a0 Archived copies of the webcasts will be available for up to one year on the \u201cInvestors\u201d section of the 4DMT website at https:\/\/ir.4dmoleculartherapeutics.com\/events. About 4DMT \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 4DMT is &hellip; Continue reading \"4DMT to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-04T12:10:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU0NyM3NTc4Mzc3IzIxOTAxMTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"4DMT to Participate in Upcoming Investor Conferences","datePublished":"2026-05-04T12:10:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/"},"wordCount":360,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU0NyM3NTc4Mzc3IzIxOTAxMTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/","name":"4DMT to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU0NyM3NTc4Mzc3IzIxOTAxMTY=","datePublished":"2026-05-04T12:10:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU0NyM3NTc4Mzc3IzIxOTAxMTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU0NyM3NTc4Mzc3IzIxOTAxMTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/4dmt-to-participate-in-upcoming-investor-conferences-7\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"4DMT to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/957516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=957516"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/957516\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=957516"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=957516"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=957516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}